Dataset Information

Zapping 500 faces in less than 100?seconds: Evidence for extremely fast and sustained continuous visual search.

ABSTRACT: A number of studies have shown human subjects' impressive ability to detect faces in individual images, with saccade reaction times starting as fast as 100?ms after stimulus onset. Here, we report evidence that humans can rapidly and continuously saccade towards single faces embedded in different scenes at rates approaching 6 faces/scenes each second (including blinks and eye movement times). These observations are impressive, given that humans usually make no more than 2 to 5 saccades per second when searching a single scene with eye movements. Surprisingly, attempts to hide the faces by blending them into a large background scene had little effect on targeting rates, saccade reaction times, or targeting accuracy. Upright faces were found more quickly and more accurately than inverted faces; both with and without a cluttered background scene, and over a large range of eccentricities (4°-16°). The fastest subject in our study made continuous saccades to 500 small 3° upright faces at 4° eccentricities in only 96?seconds. The maximum face targeting rate ever achieved by any subject during any sequence of 7 faces during Experiment 3 for the no scene and upright face condition was 6.5 faces targeted/second. Our data provide evidence that the human visual system includes an ultra-rapid and continuous object localization system for upright faces. Furthermore, these observations indicate that continuous paradigms such as the one we have used can push humans to make remarkably fast reaction times that impose strong constraints and challenges on models of how, where, and when visual processing occurs in the human brain.

SUBMITTER: Martin JG

PROVIDER: S-EPMC6102288 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Zapping 500 faces in less than 100 seconds: Evidence for extremely fast and sustained continuous visual search.

Martin Jacob G JG Davis Charles E CE Riesenhuber Maximilian M Thorpe Simon J SJ

Scientific reports 20180820 1

A number of studies have shown human subjects' impressive ability to detect faces in individual images, with saccade reaction times starting as fast as 100 ms after stimulus onset. Here, we report evidence that humans can rapidly and continuously saccade towards single faces embedded in different scenes at rates approaching 6 faces/scenes each second (including blinks and eye movement times). These observations are impressive, given that humans usually make no more than 2 to 5 saccades per secon ...[more]

PMID: 30127454

Similar Datasets

Project description:Ritonavir-boosted tipranavir (TPV/r) was evaluated as initial therapy in treatment-naïve HIV-1-infected patients because of its potency, unique resistance profile, and high genetic barrier. Trial 1182.33, an open-label, randomized trial, compared two TPV/r dose combinations versus ritonavir-boosted lopinavir (LPV/r). Eligible adults, who had no prior antiretroviral therapy were randomized to twice daily (BID) 500/100 mg TPV/r, 500/200 mg TPV/r, or 400/100 mg LPV/r. Each treatment group also received Tenofovir 300 mg + Lamivudine 300 mg QD. The primary endpoint was a confirmed viral load (VL) <50 copies/mL at week 48 without prior antiretroviral regimen changes. Primary analyses examined CD4-adjusted response rates for non-inferiority, using a 15% non-inferiority margin. At week 48, VL<50 copies/mL was 68.4%, 69.9%, and 72.4% in TPV/r100, TPV/r200, and LPV/r groups, respectively, and TPV/r groups showed non-inferiority to LPV/r. Discontinuation due to adverse events was higher in TPV/r100 (10.3%) and TPV/r200 (15.3%) recipients versus LPV/r (3.2%) recipients. The frequency of grade ?3 transaminase elevations was higher in the TPV/r200 group than the other groups, leading to closure of this group. However, upon continued treatment or following re-introduction after treatment interruption, transaminase elevations returned to grade ?2 in >65% of patients receiving either TPV/r200 or TPV/r100. The trial was subsequently discontinued; primary objectives were achieved and continuing TPV/r100 was less tolerable than standard of care for initial highly active antiretroviral therapy. All treatment groups had similar 48-week treatment responses. TPV/r100 and TPV/r200 regimens resulted in sustained treatment responses, which were non-inferior to LPV/r at 48 weeks. When compared with the LPV/r regimen and examined in the light of more current regimens, these TPV/r regimens do not appear to be the best options for treatment-naïve patients based on their safety profiles.

Dataset Information

Zapping 500 faces in less than 100?seconds: Evidence for extremely fast and sustained continuous visual search.

Publications

Zapping 500 faces in less than 100 seconds: Evidence for extremely fast and sustained continuous visual search.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets